Zurich, 28 October 2022
The Voigt Group and PHOENIX Pharma Switzerland have agreed to merge their subsidiaries, each active in pharmaceutical logistics and pharmaceutical wholesale sectors respectively, into a 50/50 joint venture. The two long-established and financially sound companies are an ideal fit with complementary offerings and competencies in the supply chain.
Subject to approval by the Swiss Competition Commission, this joint venture will create a new, competent and sustainable player in the supply chain of the Swiss healthcare market.
A CMS Switzerland team led by Dr Patrick Sommer provided comprehensive legal advice to Voigt Group on this joint venture.
CMS Switzerland:
- Dr. Patrick Sommer, Partner, Lead, Corporate / M&A, Competition & EU
- Alain Raemy, Partner, Corporate / M&A
- Marquard Christen, Partner, Competition & EU
- Dirk Spacek, Partner, Intellectual Property
- Dr Simone Brauchbar Birkhäuser, Counsel, Intellectual Property
- Hadi Mirzai, Associate, Life Sciences, Competition & EU
- Alexandra Stocker, Associate, Corporate / M&A
- Anna Mast, Associate, Corporate / M&A
- Dr. Matthias Kuert, Associate, Banking & Finance
- Thomas Zweifel, Associate, Real Estate
- Christina Winter, Associate, Employment
